Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
2,788
Views
36
CrossRef citations to date
0
Altmetric
Original Articles

Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus

Yao DengMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina
,
Jiaming LanMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina;Department of Pathogenic BiologyHebei Medical University050017ShijiazhuangHeibei ProvinceChina
,
Linlin BaoInstitute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC)MOH Key Laboratory of Human Disease Comparative Medicine100021BeijingChina
,
Baoying HuangMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina
,
Fei YeMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina
,
Yingzhu ChenMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina
,
Yanfeng YaoInstitute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC)MOH Key Laboratory of Human Disease Comparative Medicine100021BeijingChina
,
Wenling WangMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChina
,
Chuan QinInstitute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC)MOH Key Laboratory of Human Disease Comparative Medicine100021BeijingChina
&
Wenjie TanMOH Key Laboratory of Medical Virology, National Institute for Viral Disease Control and PreventionChinese Center for Disease Control and Prevention102206BeijingChinaCorrespondence[email protected]
 show all
Pages 1-10 | Received 01 Sep 2017, Accepted 11 Feb 2018, Published online: 04 Apr 2018

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Amit Joshi, Nahid Akhtar, Neeta Raj Sharma, Vikas Kaushik & Subhomoi Borkotoky. (2023) MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology. Journal of Biomolecular Structure and Dynamics 41:22, pages 12464-12479.
Read now
Naru Zhang, Jian Shang, Chaoqun Li, Kehui Zhou & Lanying Du. (2020) An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies. Expert Review of Vaccines 19:9, pages 817-829.
Read now
Jiuyang Xu, Wenxu Jia, Pengfei Wang, Senyan Zhang, Xuanling Shi, Xinquan Wang & Linqi Zhang. (2019) Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Emerging Microbes & Infections 8:1, pages 841-856.
Read now

Articles from other publishers (33)

Titus A. Olukitibi, Zhujun Ao, Bryce Warner, Rodrigo Unat, Darwyn Kobasa & Xiaojian Yao. (2023) Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection. Vaccines 11:3, pages 545.
Crossref
Nayoung Kim, Tae-Young Lee, Hansaem Lee, Jeong-Sun Yang, Kyung-Chang Kim, Joo-Yeon Lee & Hyun-Joo Kim. (2022) Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in Mice. Vaccines 10:11, pages 1843.
Crossref
Jung-ah Choi & Jae-Ouk Kim. (2022) Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies. Journal of Microbiology 60:3, pages 238-246.
Crossref
Andrés Noé & Katie Ewer. 2022. Vaccinology and Methods in Vaccine Research. Vaccinology and Methods in Vaccine Research 201 222 .
Shahad Saif Khandker, Brian Godman, Md. Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md. Ahsanul Haq, Jaykaran Charan, Ali Azam Talukder, Nafisa Azmuda, Shahana Sharmin, Mohd. Raeed Jamiruddin, Mainul Haque & Nihad Adnan. (2021) A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues. Vaccines 9:12, pages 1387.
Crossref
Medha Karnik, Narasimha M. Beeraka, Chinnappa A. Uthaiah, Suma M. Nataraj, Anjali Devi S. Bettadapura, Gjumrakch Aliev & SubbaRao V. Madhunapantula. (2021) A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development. Molecular Neurobiology 58:9, pages 4535-4563.
Crossref
Xiucui Han, Pengfei Xu & Qing Ye. (2021) Analysis of COVID‐19 vaccines: Types, thoughts, and application. Journal of Clinical Laboratory Analysis 35:9.
Crossref
Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, Preet Amol Singh, Ashish Baldi, Neha Bajwa, Raj Kumar, Lalit K. Vora, Tapan A. Patel, Maxim D. Oleynikov, Dhruvkumar Soni, Pravin Yeapuri, Insiya Mukadam, Rajashree Chakraborty, Caroline G. Saksena, Jonathan Herskovitz, Mahmudul Hasan, David Oupicky, Suvarthi Das, Ryan F. Donnelly, Kenneth S. Hettie, Linda Chang, Howard E. Gendelman & Bhavesh D. Kevadiya. (2021) Nanocarrier vaccines for SARS-CoV-2. Advanced Drug Delivery Reviews 171, pages 215-239.
Crossref
Soheila Molaei, Masoomeh Dadkhah, Vahid Asghariazar, Chiman Karami & Elham Safarzadeh. (2021) The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies. International Immunopharmacology 92, pages 107051.
Crossref
Lanxiang Huang, Yuan Rong, Qin Pan, Kezhen Yi, Xuan Tang, Qian Zhang, Wei Wang, Jianyuan Wu & Fubing Wang. (2021) SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies. Asian Journal of Pharmaceutical Sciences 16:2, pages 136-146.
Crossref
Halle Lutz, Kristen D. Popowski, Phuong-Uyen C. Dinh & Ke Cheng. (2021) Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019. Advanced NanoBiomed Research 1:3.
Crossref
Fataneh Fatemi, Zahra Hassani Nejad & Seyed Ehsan Ranaei Siadat. 2021. COVID-19. COVID-19 149 185 .
Jeremy Baldwin & Nikolai Petrovsky. 2021. Human Viruses: Diseases, Treatments and Vaccines. Human Viruses: Diseases, Treatments and Vaccines 533 549 .
Yen-Der Li, Wei-Yu Chi, Jun-Han Su, Louise Ferrall, Chien-Fu Hung & T.-C. Wu. (2020) Coronavirus vaccine development: from SARS and MERS to COVID-19. Journal of Biomedical Science 27:1.
Crossref
Reza Zolfaghari Emameh, Hassan Nosrati & Ramezan Ali Taheri. (2020) Combination of Biodata Mining and Computational Modelling in Identification and Characterization of ORF1ab Polyprotein of SARS-CoV-2 Isolated from Oronasopharynx of an Iranian Patient. Biological Procedures Online 22:1.
Crossref
Ju Kim, Ye Lin Yang, Yongsu Jeong & Yong-Suk Jang. (2020) Conjugation of Human β-Defensin 2 to Spike Protein Receptor-Binding Domain Induces Antigen-Specific Protective Immunity against Middle East Respiratory Syndrome Coronavirus Infection in Human Dipeptidyl Peptidase 4 Transgenic Mice. Vaccines 8:4, pages 635.
Crossref
J S Tregoning, E S Brown, H M Cheeseman, K E Flight, S L Higham, N-M Lemm, B F Pierce, D C Stirling, Z Wang & K M Pollock. (2020) Vaccines for COVID-19. Clinical and Experimental Immunology 202:2, pages 162-192.
Crossref
Yetian Dong, Tong Dai, Yujun Wei, Long Zhang, Min Zheng & Fangfang Zhou. (2020) A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduction and Targeted Therapy 5:1.
Crossref
Subodh Kumar Samrat, Anil M. Tharappel, Zhong Li & Hongmin Li. (2020) Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development. Virus Research 288, pages 198141.
Crossref
Tania Gupta & Shishir K Gupta. (2020) Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses. International Immunopharmacology 86, pages 106717.
Crossref
Jawad Al-Kassmy, Jannie Pedersen & Gary Kobinger. (2020) Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?. Viruses 12:8, pages 861.
Crossref
Ren Yang, Jiaming Lan, Baoying Huang, Ruhan A, Mingqing Lu, Wen Wang, Wenling Wang, Wenhui Li, Yao Deng, Gary Wong & Wenjie Tan. (2020) Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections. EBioMedicine 58, pages 102890.
Crossref
Ahmed Mostafa, Ahmed Kandeil, Mahmoud Shehata, Rabeh El Shesheny, Abdallah M. Samy, Ghazi Kayali & Mohamed A. Ali. (2020) Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science. Microorganisms 8:7, pages 991.
Crossref
Chunting He, Ming Qin & Xun Sun. (2020) Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight. Acta Pharmaceutica Sinica B 10:7, pages 1175-1191.
Crossref
Cristiano Conte, Francesco Sogni, Paola Affanni, Licia Veronesi, Alberto Argentiero & Susanna Esposito. (2020) Vaccines against Coronaviruses: The State of the Art. Vaccines 8:2, pages 309.
Crossref
Eriko Padron-Regalado. (2020) Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains. Infectious Diseases and Therapy 9:2, pages 255-274.
Crossref
Trevor R. F. Smith, Ami Patel, Stephanie Ramos, Dustin Elwood, Xizhou Zhu, Jian Yan, Ebony N. Gary, Susanne N. Walker, Katherine Schultheis, Mansi Purwar, Ziyang Xu, Jewell Walters, Pratik Bhojnagarwala, Maria Yang, Neethu Chokkalingam, Patrick Pezzoli, Elizabeth Parzych, Emma L. Reuschel, Arthur Doan, Nicholas Tursi, Miguel Vasquez, Jihae Choi, Edgar Tello-Ruiz, Igor Maricic, Mamadou A. Bah, Yuanhan Wu, Dinah Amante, Daniel H. Park, Yaya Dia, Ali Raza Ali, Faraz I. Zaidi, Alison Generotti, Kevin Y. Kim, Timothy A. Herring, Sophia Reeder, Viviane M. Andrade, Karen Buttigieg, Gan Zhao, Jiun-Ming Wu, Dan Li, Linlin Bao, Jiangning Liu, Wei Deng, Chuan Qin, Ami Shah Brown, Makan Khoshnejad, Nianshuang Wang, Jacqueline Chu, Daniel Wrapp, Jason S. McLellan, Kar Muthumani, Bin Wang, Miles W. Carroll, J. Joseph Kim, Jean Boyer, Daniel W. Kulp, Laurent M. P. F. Humeau, David B. Weiner & Kate E. Broderick. (2020) Immunogenicity of a DNA vaccine candidate for COVID-19. Nature Communications 11:1.
Crossref
Petra Zimmermann & Nigel Curtis. (2020) Coronavirus Infections in Children Including COVID-19. Pediatric Infectious Disease Journal 39:5, pages 355-368.
Crossref
Pureum Lee & Doo-Jin Kim. (2020) Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19. Immune Network 20:4.
Crossref
Y.-D. Li, W.-Y. Chi, J.-H. Su, L. Ferrall, C.-F. Hung & T.-C. Wu. (2020) CORONAVIRUS VACCINE DEVELOPMENT: FROM SARS AND MERS TO COVID-19 (RUSSIAN TRANSLATION). Juvenis Scientia 6:6, pages 41-80.
Crossref
Craig Schindewolf & Vineet Menachery. (2019) Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism. Viruses 11:1, pages 74.
Crossref
Zhiqi Song, Yanfeng Xu, Linlin Bao, Ling Zhang, Pin Yu, Yajin Qu, Hua Zhu, Wenjie Zhao, Yunlin Han & Chuan Qin. (2019) From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses 11:1, pages 59.
Crossref
Jiaming Lan, Yao Deng, Jingdong Song, Baoying Huang, Wenling Wang & Wenjie Tan. (2018) Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus. Virologica Sinica 33:5, pages 453-455.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.